Key Words: ALLERGY: anaphylactoid, Haemaccel, polygeline; ANAESTHESIA, ANESTHESIA: general Polygeline (Haemaccel®, Hoechst) is a colloid type intravenous fluid produced by hydrolysis of collagen. It has a mean molecular weight of 35,000 (range 5000-50,000) and is presented as a 3.5% solution, sterile and pyrogen-free. 1 The clinical indications for the use of Polygeline include hypovolaemia and haemodilution. I ,2 Caution has been recommended in its use in asthma 1 and phaeochromocytoma,2 where histamine release may cause significant morbidity. Anaphylactoid reactions to gelatin solutions are rare. 3 The occurrence of three such reactions over a period of one month was unexpected and prompted this report.
CASE 1
A 57-year-old man weighing 77 kg, with a threeyear history of exertional angina was scheduled for aorto-coronary bypass grafting following unsuccessful angioplasty one week previously. No other medical problems were evident. There was no history of allergy. Physical examination was unremarkable. His blood pressure was 130175 mmHg and he had a normal ECG. Medication consisted of nifedipine 10 mg q.i.d.
On the morning of surgery he received his usual dose of nifedipine and was premedicated with pethidine 100 mg, promethazine 25 mg and hyoscine 0.3 mg intramuscularly. Prior to induction, two intravenous lines and a radial artery line were inserted. To the intravenous lines were connected Haemaccel 500 m1 (according to the protocol which was in use at that time for autologous blood collection) and Hartmann's solution 1000 ml respectively. The lines were flushed with those solutions. The patient received approximately 50 ml of Haemaccel. His blood pressure was 125170 mmHg and heart rate 72 beats per minute.
While still in the anaesthetic bay he complained of nausea. His blood pressure was found to be 65/40 mmHg. He was given two doses of metaraminol 0.5 mg and the' Haemaccel was changed to Hartmann's solution. He remained conscious with good volume femoral pulses but his blood pressure was still 65/30 mmHg. Over the next two minutes he developed an erythematous rash over his face and trunk. At no time did he develop bronchospasm. He was now receiving Stable Plasma Protein Solution (SPPS) rapidly and adrenaline in incremental doses to 0.4 mg. His blood pressure rose to 80/60 mmHg, but ST segment depression developed on ECG. By the time 1000 m1 of SPPS had been infused, and a further 0.4 mg of adrenaline given, his pressure was 115/55 mmHg. Because 'he had evidence of myocardial ischaemia, we proceeded urgently with his sternotomy to achieve cardiopulmonary bypass, myocardial protection and ultimately, coronary revascularisation. He was induced with diazepam 5 mg, pancuronium 12 mg and fentanyl in incremental doses to 500 mcg. He received a further 0.2 mg of adrenaline and 8 mg of dexamethasone. A glyceryl trinitrate infusion was commenced. He remained haemodynamically stable, ST segments returned to normal and he proceeded to uneventful coronary artery grafting to three vessels. His post bypass period was uneventful.
CASE 2
A 59-year-old woman weighing 68 kg with a history of increasing dyspnoea over several years was scheduled for aortic valve replacement for severe aortic stenosis. Her medical history included the development of an erythematous skin reaction to elastoplast, and vaginal pruritis related to sulindac. She was not on any medications. She was premedicated with pethidine 75 mg, promethazine 25 mg and hyoscine 0.3 mg intramuscularly.
Two peripheral venous lines and a radial arterial line were inserted under local anaesthesia with procaine. Diazepam 2.5 mg was also given to add to the sedative effect of the premedication. In the operating room, she was induced with fentanyl 500 mcg, pancuronium 12 mg and diazepam 7.5 mg. She was ventilated by mask with nitrous oxide and oxygen (FI02 0.5) and intubated. Mechaniciu ventilation was commenced. End-tidal carbon dioxide tension was controlled to 35-40 mmHg. Blood pressure remained stable at 125/80 mmHg. The patient also received cephalothin 1.0 gm intravenously at the time of induction. Ten minutes after induction her blood pressure suddenly fell to 70/50 mmHg. Some autologous blood had been taken and the volume replaced with Haemaccel to avoid hypovolaemia. Her median sternotomy had just commenced. When her blood pressure fell she was given more Haemaccel. Her blood pressure did not respond adequately and she was given metaraminol 0.5 mg increments to 2.0 mg and was ventilated with 100% oxygen. An erythematous rash over her head and neck was observed. She then received two doses of adrenaline 0.1 mg while an adrenaline infusion was commenced at 0.08 micrograms per kg per minute. She responded and her blood pressure increased to 100/50 mmHg. However, treatment was complicated by a run of ventricular tachycardia for which she was internally defibrillated with one 10 joule DC shock. She reverted to sinus rhythm, rate 100 beats per minute with a blood pressure of 110/ 50 mmHg. Arterial blood gases were satisfactory and her venous oxygen saturation going onto cardiopulmonary bypass was never below 65%. She proceeded to uneventful aortic valve replacement. At the completion of surgery the rash was also noted to be present over her trunk and it subsided over eight hours. CASE 
3
A 58-year-old man weighing 81 kg with a history of recent transient ischaemic attacks was scheduled for left carotid endarterectomy. He had a past history of hypertension and hypercholesterolaemia. Preoperative medications consisted of atenolol50 mg daily, nifedipine 25 mg SR daily and clofibrate 1.0 g b.d. He had no history of allergy and had undergone several previous anaesthetics uneventfully. Physical examination was unremarkable. His blood pressure was well controlled. ECG and chest X-ray were normal.
Premedication consisted of pethidine 75 mg and atropine 0.6 mg intramuscularly. Anaesthesia consisted of thiopentone 325 mg, fentanyl 200 mcg and pancuronium 8 mg with maintenance of oxygen 40% in nitrous oxide with isoflurane supplementation. n>PV with an end-tidal carbon dioxide concentration of 15 mmHg was established. Anaesthesia was unremarkable during dissection, clamping and de-clamping of the carotid arteries. Heparin 5000 units was administered prior to clamping and this was later reversed with protamine 50 mg. During closure of the wound, systolic blood pressure had fallen to 110 mmHg. In view of moderate estimated blood loss of 400 ml, Haemaccel was commenced. Five minutes later systolic blood pressure fell rapidly to 65 mmHg. Oxygen 100% and increments of metaraminol to 4 mg were given with good effect over the following five minutes, with systolic blood pressure now greater than 100 mmHg.
On undraping the patient at completion of surgery a fine urticarial rash was noted. No bronchospasm was evident at any stage. The pancuronium was antagonised with neostigmine and atropine. He was extubated when obeying commands and transferred to the intensive care unit. The rash regressed over the ensuing twelve hours and his postoperative course was uncomplicated.
DISCUSSION
Reactions to Haemaccel have been sporadically reported. 4 -7 Some reactions associated with bronchospasm have resulted in death. 4 ,5 Reactions are more likely ifHaemaccel is infused rapidly, and if the patient is normovolaemic. I ,8 Reactions to colloid plasma expanders have been classified by Ring and Messmer 3 as in Table 1 . The mechanism for these reactions has been shown to be due to direct histamine release rather than to antigen/antibody reactions. 9 ,lo The histamine release is thought to be mediated via hexamethylene di-isocyanate which has variable concentrations from batch to batch. I I 'Purified' Haemaccel was developed by reducing the amount of hexamethylene di-isocyanate as compared with that present in 'classical' Haemaccel, and has been in use since 1979. 11 The incidence of severe anaphylactoid reactions to Haemaccel appears to have been subsequently reduced. 12 The incidence of reactions has differed in published reports. Ring and Messmer in an occasional survey3 showed an overall incidence of 0.115% of reactions, and a 0.038% incidence of severe reactions (shock, cardiac and/or respiratory arrest) to gelatins. Minor reactions from Haemaccel have been quoted from 30 to 50% in controlled studies in humans. 11 After the introduction of purified Haemaccel, Weis 12 demonstrated reactions in nine out of 1147 patients of which eight were cutaneous and only one was grade 1I according to the classification of Ring and Messmer. There were no grade III or IV reactions. Measurements of plasma histamine have revealed levels significantly lower when 'purified' Haemaccel is used rather than the 'classical' preparation. 11 It is apparent that the modification of Haemaccel has reduced the risk of severe reactions secondary to histamine release. It should be added that prior to this purification, the conclusions of Ring and Messmer 3 were that the incidence of reactions was low and should not preclude its use.
In our cases the diagnoses were made on the basis of cutaneous manifestations with circulatory disturbance together with a strong temporal relationship to Haemaccel administration. They were grade III reactions according to the classification of Ring and Messmer. None of these cases developed bronchospasm and this reduced the complexity of the clinical problem in each case. Management in cases 1 and 2 consisted of oxygen, fluids, and adrenaline with satisfactory results. Metaraminol was used initially as it is routinely prepared preoperatively for cardiac surgery in our institution and was hence available. Adrenaline was used once the diagnosis was evident. In case 3 the patient responded to oxygen and metaraminol. Positive skin tests as a diagnostic aid have been reported in patients; 13 however, not all centres have found them to be of value. 14 They were not performed on these patients.
All three patients were either normovolaemic or only modestly hypovolaemic at the time that the Haemaccel was administered. This may have been a significant factor. 1 ,g In cases 2 and 3, the rate of infusion was initially increased in response to the hypotension and this may have exaccerbated the reaction.
All three bottles of Haemaccel were from the same batch which had been distributed to several countries over a two-month period. On contacting Hoechst Australia, we were informed that no other reports of reactions had been received and that they considered contamination of the batch extremely unlikely.
HI and H2 antagonists have been used successfully to prevent the occurrence of minor cutaneous reactions. 15, 16 Life-threatening reactions in dogs have been demonstrated to be preventable or diminished in severity with HI and H2 antagonists. 15 As the overall incidence of systemic reactions in clinical studies is low, it is questionable that routine premedication with HI and H2 blockers is warranted. Certainly, these drugs must be used prophylactically if they are to be effective.
Haemaccel remains a useful plasma expander in many situations but this must be carefully weighed against possible reactions. In Australia, the Adverse Drug Reactions Advisory Committee received 34 reports involving Haemaccel from November 1972 until July 1988. 17 Of the eighteen reports in which Haemaccel was the sole suspected agent, 13 were classified as anaphylactoid. Although supporting the concept that these reactions are not common, it reinforces the fact that serious reactions do occur.
